Profil bibliographique

Brigitta G. Baumert

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

255Publications signalées

18747Citations signalées

3Affiliations récentes

Institutions déclarées

Medisch Centrum Haaglanden Kantonsspital Graubünden Maastro Clinic

Domaines associés

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma managementRadiomics and Machine Learning in Medical ImagingAdvanced Radiotherapy Techniques

Publications récentes

2026 articleOpenAlex

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU)

Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent, Andreas von Deimling et autres

4 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis

Ogechukwu A Asogwa, Linda Dirven, Neil K Aaronson, Brigitta G. Baumert et autres

0 citationsZurich Open Repository and Archive (University of Zurich)

Accès ouvert 2026 erratumOpenAlex

Corrigendum to “ESTRO/EANO recommendation on reirradiation of glioblastoma” [Radiother. Oncol. 204 (2025) 110696]

Nicolaus Andratschke, Astrid E. Heusel, Nathalie L. Albert, Filippo Alongi et autres

0 citationsRadiotherapy and Oncology

Accès ouvert 2026 articleOpenAlex

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis

Ogechukwu A Asogwa, Linda Dirven, Neil K Aaronson, Brigitta G. Baumert et autres

1 citationThe Oncologist

2026 articleOpenAlex

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

Martin J. van den Bent, Santoesha A. Ghisai, Wolfgang Wick, Marc Sanson et autres

0 citationsLirias (KU Leuven)

Accès ouvert 2025 articleOpenAlex

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

Martin J van den Bent, S A Ghisai, Wolfgang Wick, M. Sanson et autres

13 citationsThe Lancet Oncology

Accès ouvert 2025 articleOpenAlex

O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial

Anca‐Ligia Grosu, Wolfgang Weber, Erika Graf, Michael Mix et autres

5 citationsThe Lancet Oncology

Accès ouvert 2025 conference-abstractOpenAlex

QOL-26. Health-Related Quality of Life in Molecular Glioma Subtypes: A Pooled Analysis from 16 Randomized Trials

Ogechukwu A Asogwa, Linda Dirven, Alba A. Brandes, Annika Malmström et autres

0 citationsNeuro-Oncology

Accès ouvert 2025 articleOpenAlex

European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project

E. Razis, Thierry Gorlia, Matthias Preusser, Jean‐François Daisne et autres

0 citationsNeuro-Oncology Practice

Accès ouvert 2025 conference-abstractOpenAlex

OS01.7.A AGE AND SEX AS RISK FACTORS FOR HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN GLIOMA PATIENTS: POOLED ANALYSES OF CLINICAL TRIALS FROM THE CODAGLIO 2.0 DATABASE

O A Edeh-Asogwa, Martin Taphoorn, Alba A. Brandes, Andrea Pace et autres

0 citationsNeuro-Oncology

Accès ouvert 2025 conference-abstractOpenAlex

OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.

Martin J. van den Bent, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak et autres

0 citationsNeuro-Oncology

Accès ouvert 2025 conference-abstractOpenAlex

Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.

Martin J. van den Bent, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak et autres

5 citationsJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.